Boehringer Ingelheim and Zai Lab launch a clinical collaboration to evaluate a dual DLL3‑targeting combination therapy in small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs).
Data Demonstrate Activity in HER2-Low and ADC-Resistant Tumor Models, Supporting Advancement Toward IND SHANGHAI and SUZHOU, China, April 14, 2026 /PRNewswire/ -- Phrontline Biopharma today announced ...
CHICAGO - Tempus AI, Inc. announced a collaboration with Daiichi Sankyo (TSE:4568) to support the clinical development of an antibody drug conjugate program in oncology, according to a press release ...
They call her "the butterfly lady." In the fall, when migrating monarch butterflies start appearing in Silver City to dine ...
A judge has allowed Lil Nas X to enter a mental health diversion program intended to lead to the dismissal of charges of ...
When the 2026-27 school year begins, SUNY Niagara will have a new team on campus after the addition of a new women’s ...
Detailed price information for C-COM Satellite Sys Inc (CYSNF) from The Globe and Mail including charting and trades.
A little more than a month after construction of the Hudson River Tunnel resumed, crews are working assembling the specialized machines necessary to dig the first stage ...
North Carolina basketball has one name that's not the top candidate to replace Hubert Davis but may be the best fit at a ...
The program is on a mission to provide 300 student homes with free internet through Space X's Starlink satellites.
The child was taken to a hospital and later died from cardiac arrest as a result of sepsis. Her father is accused of failing ...
No tailhook required to earn wings of gold?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results